Key Details of Subsidiary
- Name of Entity: Vimta Labs LLC
- Country of Incorporation: United States of America (USA)
- Date of Incorporation: September 24, 2026
- Industry: Contract Research Organization (CRO)
Relationship with Listed Entity
Vimta Labs LLC has been incorporated as a Wholly Owned Subsidiary of Vimta Labs Limited. The listed entity holds 100% of the shareholding in the subsidiary.
Business Background
The subsidiary will support the parent company's core business lines, which include Preclinical Studies, Clinical Trials & Analytical testing for the Pharmaceutical & growing Biologics CRAD Services. Vimta LLC is described as a newly incorporated entity that will operate as a contract research and testing organization (CRO/CRTO).
Investment Details
- Nature of Consideration: 100% subscription to initial paid-up capital is in Cash
- Total Investment Amount: USD 8,500
- Investment Structure: The investment will be made in one or more tranches as per business requirement
- Percentage of Control: Vimta Labs Limited holds 100% ownership
Regulatory Approvals
No governmental or regulatory approvals were required for the incorporation, as stated: "Not Applicable (The Incorporation of wholly owned subsidiary Company will be done as per the applicable laws in the USA)".
Corporate Governance
- Board Meeting Date: October 30, 2026
- Previous Intimation: Reference made to earlier intimation dated May 6, 2026
- Regulatory Reference: SEBI Master Circular No. HO/49/14/14(7)2025-CFD-POD2/I/3 62 2026 issued on January 30, 2026
Financial Impact
The disclosure specifies the total investment amount of USD 8,500, but does not provide additional financial impact quantification regarding operational costs, revenue projections, or balance sheet impact.